Leuko
Ephraim Hochberg is an accomplished medical professional with extensive experience in oncology and clinical operations. Currently serving as a Scientific Advisor at Leuko and an Assistant Professor in Medicine at Harvard Medical School, Hochberg also holds the position of Associate Clinical Director at the Massachusetts General Hospital Cancer Center, overseeing ambulatory and inpatient operations. Their past roles include Clinical Director of Inpatient Medical Oncology and Director of Clinical Lymphoma Research, demonstrating a strong commitment to improving cancer care. Hochberg's experience includes consulting roles at Intervention Insights and Flatiron Health, as well as academic positions at Dana-Farber Cancer Institute and Brigham and Women's Hospital. Hochberg earned an MD from Case Western Reserve University and a BA in Biology from Yale University.
This person is not in the org chart
This person is not in any teams
Leuko
Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is the first-line indicator for various medically relevant situations, ranging from chemotherapy management to the detection of life-threatening infections worldwide.